Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD) is a Drug Manufacturers - General company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $193B; returns 1 day -0.7%, 1 week -0.1%, 1 year +29.2%.

Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines in areas of unmet medical need. The company's core therapeutic areas include HIV/AIDS, liver diseases, hematology/oncology, inflammation, and respiratory diseases. Gilead generates revenue primarily through the sale of its pharmaceutical products.

Groups GILD belongs to

• Dividend Payers
• Healthcare
• Biotechnology
• Biopharmaceutical
• S&P 500
• Pharmaceuticals
• Life Sciences
• Oncology
• Unmet Medical Needs
• Breast Cancer Treatment
• Liver Disease
• Infectious Diseases
• Commercial Stage
• Hematology
• Biologics
• Immunotherapy

GILD financial model: income statement, cash flow and balance sheet